This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Aug. 16, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management


Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Fall Managed Care Forum
November 8-9
Bellagio Hotel

 




 Genomics

Despite fears of Alzheimer's, many would like to know their risk
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Alzheimer's disease can't be prevented or cured, and it ranks second only to cancer among diseases that people fear. Still, in an international study last year from the Harvard School of Public Health, about two-thirds of respondents from the United States said they would want to know if they were destined to get the disease. More



From dozens of genomes, clues to rare diseases
Stanford University via Futurity    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers are trying to identify genes underlying rare, recessive diseases that mainly crop up in populations with a high number of marriages among close relatives by examining genomes from dozens of world populations. More

Now Hiring! Disability Examination Providers

The VA Locum Tenens Program seeks physicians and psychologists to perform disability examinations for general medicine and mental health conditions. Physicians will provide compensation and pension examinations for Veterans who file for disability claims. This position requires extensive travel around the country. Compensation package includes salary and full travel. Send your CV to locumtenens@va.gov or contact us at 1-866-664-1030.


Gene tied to emergency of chemotherapy resistance
Genetic Engineering & Biotechnology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers say analyzing a particular gene in high-grade serous cancer could help predict whether a patient's tumor is likely to become resistant to chemotherapy over time. Researchers have found that the emergence of treatment resistance in HGSC is associated with a loss or downregulation of the lipid transporter LRPB1 in the tumor. More

 Biotech/Diagnostics/Personalized Medicine


Nanoplexes deliver personalized medicine in cancer
FierceDrugDelivery    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers are combining diagnostics, therapeutics and drug delivery in a "nanoplex" to kill cancer cells without damaging healthy tissue and causing the side effects associated with many cancer therapies. The approach, which the researchers describe as "theranostic imaging," targets drugs specifically to tumor cells, and the research is published in American Chemical Society Nano. Theranostics, using a diagnostic to tailor choice of therapeutics, are a key part of personalized medicine. More

CARDIODX®

Your patient's blood doesn't tell you that they will get tired walking the dog. Or that they've had heartburn for the past 2 weeks. But it can tell you whether or not obstructive CAD is what's causing their symptoms. You may not need to go deeper than the blood to know what's happening. MORE


Blood type might be clue to heart disease risk
The Associated Press via USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Here's another reason to know your blood type — it might be a clue to your risk of heart disease. People who have blood types A, B, or AB have a slightly higher risk of heart disease compared to those with type O, the most common kind, according to new research. More


Pharmaceutical products that make a difference
Forest has well-established franchises in the therapeutic areas of the central nervous and cardiovascular systems and are always exploring new product opportunities. MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE


 Regenerative Medicine


Clinic taps patients' own stem cells to ease their pain
Star Tribune    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A Sartell, Minn., doctor offers the treatment instead of surgery, but critics say it's too soon. The trend has triggered a simmering debate in medicine and at least one federal court over who should decide when a treatment that basically uses a patient's own cells is ready for prime time. More

 Emerging Medical Technologies


Effort aims to land returning veterans in medical device jobs
The Boston Globe    Share    Share on FacebookTwitterShare on LinkedinE-mail article
AdvaMed 2012, the national medical device industry convention, will launch a program designed to increase the hiring of U.S. veterans returning to civilian life. The initiative, called MedTech Veterans Program Boot Camp for Returning Heroes, was recently previewed. Noting that returning veterans face unemployment rates more than 50 percent higher than the U.S. population at large, Marine Corps veteran Kevin Blanchard told medical technology executives, "You guys are taking the first step in providing some solutions to returning veterans. Let's get these guys hired." More

FDA OKs 'talking' injector
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The FDA has approved the first voice-guided epinephrine injection device for treatment of severe allergic reactions. The device, which gives verbal step-by-step instructions, can be used by children weighing at least 33 pounds who are at risk for, or have a history of, anaphylaxis. More

 Managed Healthcare News


A giant hospital chain is blazing a profit trail
The News York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
During the Great Recession, when many hospitals across the country were nearly brought to their knees by growing numbers of uninsured patients, one hospital system not only survived — it thrived. In fact, profits at the healthcare industry giant HCA, which controls 163 hospitals from New Hampshire to California, have soared, far outpacing those of most of its competitors. The financial performance has been so impressive that HCA has become a model for the industry. More

Regulators urged to move swiftly to prevent 'rate shocks'
Kaiser Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Consumer groups said state and federal regulators should move quickly to set rules to protect Americans from health insurance premium "rate shocks" and to prevent insurers from charging far higher rates in low income areas, when major provisions of the federal health law take effect in 2014. More

 FDA: New Treatments and Technology


FDA warns of death risk from codeine in some post-surgery children
U.S. Food and Drug Administration    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration has issued a Drug Safety Communication concerning three children who died and one child who experienced a non-fatal but life-threatening case of respiratory depression after taking the pain reliever codeine following surgery to remove tonsils and/or adenoids. The surgeries were performed to treat obstructive sleep apnea syndrome, a condition that results in repeated episodes of complete or partial blockage of the upper airway during sleep. The children received doses of codeine that were within the typical dose range. More

FDA approves new flu vaccine for 2012-2013 season
The Associated Press via CBS News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The new flu vaccine for the upcoming 2012-2013 influenza season has been approved by The Food and Drug Administration. Each year the FDA works with the Centers for Disease Control and Prevention and the World Health Organization to design a vaccine to protect against the three viral strains most likely to cause the flu in the upcoming year. The newest vaccine has one strain in common with 2011's vaccine, plus two new viral strains it's targeting. More

FDA warns Hershey over chocolate syrup labeling
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Hershey Co made nutritional claims for its chocolate syrups that do not meet regulatory guidelines, the U.S. Food and Drug Administration said. In a warning letter to the company, the FDA said the labels on Hershey's Syrup+Calcium and its Syrup Sugar Free with Vitamin & Mineral Fortification violate federal law. More

FAST FACTS
"According to the Centers for Disease Control and Prevention, people who should not get the flu vaccine without first consulting a physician include those with a severe allergy to chicken eggs, a severe reaction to a flu vaccine and children younger than 6 months old."
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Aug. 9, 2012
Aug. 2, 2012
July 26, 2012
July 19, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063